The long-term objective is to determine the impact of environmental toxicants on the olfactory system and the role of chemical exposure in the etiology of anosmia and other diseases concerning the nasal cavity, such as nasal polyps, chronic nasal inflammation, microbial infection, and asthma. Our focus has been on the mechanisms of tissue-specific toxicity and molecular approaches to risk assessment. Previous in vitro studies have suggested that olfactory mucosa (OM)-predominant cytochrome P450 (CYP) enzymes may be important in the OM-selective toxicity of many chemicals. In the current funding period, we have succeeded in the preparation and initial characterization of two knockout mouse models, one with germ-line disruption of the OM-specific Cyp2gl gene (Cyp2gl-null mouse), the other with liver-specific deletion of the NADPH-cytochrome P450 reductase (Cpr) gene (liver-Cpr-null mouse). Using these models, we have obtained important preliminary data concerning the role of hepatic metabolism in nasal toxicity of acetaminophen (as a model toxicant), and the role of CYP2A5 and/or CYP2G1 in the toxicity of acetaminophen in the lateral nasal gland (LNG). In the proposed studies, we will test a general hypothesis that target tissue metabolic activation is critical for extrahepatic chemical toxicity; however, the sensitivity of a particular tissue to a given compound will depend on many factors (in addition to the rate of systemic clearance of the parent compound), such as the level and reactivity of circulating hepatic metabolites, and homeostasis of endogenous substrates in the target tissue.
The specific aims are: 1) To determine the impact of hepatic metabolism and target tissue metabolic activation on OM toxicity of nasal toxicants; 2) To determine the mechanisms of the increased resistance to AP toxicity in the LNG of the Cyp2gl-null mouse; and 3) To generate additional mouse models that can be used for determining the specific roles of CYP2A5 and CYP2G1 in target tissue metabolic activation and chemical toxicity in the OM and LNG. These studies will have broad implications for risk assessment of potential nasal toxicants, and may serve as a model for studying mechanisms of chemical toxicity in other extrahepatic tissues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES007462-10
Application #
6783765
Study Section
Special Emphasis Panel (ZRG1-GMA-3 (03))
Program Officer
Lawler, Cindy P
Project Start
1994-09-15
Project End
2008-06-30
Budget Start
2004-09-30
Budget End
2005-06-30
Support Year
10
Fiscal Year
2004
Total Cost
$316,700
Indirect Cost
Name
Wadsworth Center
Department
Type
DUNS #
153695478
City
Menands
State
NY
Country
United States
Zip Code
12204
Hu, Jinping; Sheng, Li; Li, Lei et al. (2014) Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene. Drug Metab Dispos 42:23-7
Xie, Fang; Fang, Cheng; Schnittke, Nikolai et al. (2013) Mechanisms of permanent loss of olfactory receptor neurons induced by the herbicide 2,6-dichlorobenzonitrile: effects on stem cells and noninvolvement of acute induction of the inflammatory cytokine IL-6. Toxicol Appl Pharmacol 272:598-607
Xie, Fang; D'Agostino, Jaime; Zhou, Xin et al. (2013) Bioactivation of the nasal toxicant 2,6-dichlorobenzonitrile: an assessment of metabolic activity in human nasal mucosa and identification of indicators of exposure and potential toxicity. Chem Res Toxicol 26:388-98
Wei, Yuan; Li, Lei; Zhou, Xin et al. (2013) Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model. Drug Metab Dispos 41:132-40
Riddick, David S; Ding, Xinxin; Wolf, C Roland et al. (2013) NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology. Drug Metab Dispos 41:12-23
Wei, Yuan; Wu, Hong; Li, Lei et al. (2012) Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model. Drug Metab Dispos 40:1144-50
Fang, C; Bolivar, V J; Gu, J et al. (2012) Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model. Neuroscience 218:170-80
Zhou, Xin; D'Agostino, Jaime; Li, Lei et al. (2012) Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models. Drug Metab Dispos 40:642-7
Hough, Lindsay B; Nalwalk, Julia W; Yang, Jun et al. (2011) Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic. Pain 152:878-87
Zou, Ling; Li, Li; Porter, Todd D (2011) 7-Dehydrocholesterol reductase activity is independent of cytochrome P450 reductase. J Steroid Biochem Mol Biol 127:435-8

Showing the most recent 10 out of 70 publications